NCT06043297View on ClinicalTrials.gov

Bioequivalence Study of Two Products of Apixaban 5mg Tablets in Healthy, Adult, Human Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 23, 2023

Primary Completion Date

March 6, 2023

Study Completion Date

April 27, 2023

Conditions
Antithrombic Drug
Interventions
DRUG

Apixaban 5MG

Each film-coated tablet contains 5 mg apixaban

DRUG

Eliquis 5 mg

Each film-coated tablet contains 5 mg apixaban

Trial Locations (1)

382481

Lambda Therapeutic Research Ltd., Ahmedabad

All Listed Sponsors
collaborator

Yunus sancak

UNKNOWN

lead

Humanis Saglık Anonim Sirketi

INDUSTRY